562 THE JAK INHIBITOR TOFACITINIB RESCUES INTESTINAL BARRIER DEFECTS AND DISRUPTED EPITHELIAL-MACROPHAGE CROSSTALK CAUSED BY LOSS OF PTPN2 ACTIVITY IN VITRO AND IN VIVO

Authors :: Alina N. Santos
Stephanie J. King
Anica Sayoc-Becerra
Moorthy Krishnan
Marianne R. Spalinger
Christ Ordookhanian
Vinicius Canale
Declan F. McCole
Michael Scharl
Source :: Gastroenterology. 158:S-115
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Crosstalk (biology)
Tofacitinib
Hepatology
In vivo
Chemistry
Gastroenterology
In vitro
Cell biology

Full Text Access

Tools